How should calcium pyrophosphate dihydrate crystal deposition disease with medial and lateral meniscal calcifications be treated, given that physical therapy is ineffective?

Treatment of CPPD with Meniscal Calcifications

For asymptomatic meniscal calcifications from CPPD, no treatment is required; however, if symptoms develop, treatment should be directed at the specific clinical manifestation (acute attacks, chronic inflammation, or recurrent flares) rather than the calcifications themselves, as no therapy currently dissolves CPP crystals. 1

Key Principle: Treat the Clinical Manifestation, Not the Calcification

The presence of meniscal calcifications (chondrocalcinosis) alone does not require treatment. Currently, no treatment modifies CPP crystal formation or dissolution, and no treatment is required for asymptomatic chondrocalcinosis 1. The calcifications you see on imaging are permanent markers of CPPD but are not themselves the treatment target.

Treatment Algorithm Based on Clinical Presentation

If Asymptomatic (Isolated Chondrocalcinosis)

• No pharmacological treatment needed 1
• Screen for associated metabolic conditions: hyperparathyroidism, hemochromatosis, hypomagnesemia 1
• Educate patient about potential future symptoms

If Acute CPP Crystal Arthritis Develops

First-line approach (strength of recommendation 95%): 1

• Ice or cool packs
• Temporary rest
• Joint aspiration with intra-articular glucocorticoid injection (long-acting formulation)
• For many patients, these measures alone are sufficient

If systemic therapy needed:

1. Low-dose oral colchicine: 0.5 mg up to 3-4 times daily (avoid traditional high-dose regimens due to 100% side effect rate) 1
2. Oral NSAIDs with gastroprotection (especially critical in elderly patients) 1
3. If contraindications to above or polyarticular disease:
   • Short tapering course of oral glucocorticoids, OR
   • Parenteral glucocorticoids (betamethasone 7 mg IM or methylprednisolone 125 mg IV - NNT=3 for rapid pain control on day 1) 1
   • ACTH 40-80 units (resolves attacks in average 4.2 days) 1

If Recurrent Acute Attacks (Prophylaxis Needed)

Prophylactic therapy (strength of recommendation 81%): 1

• Low-dose colchicine: 0.5-1 mg daily (reduces attack frequency from 3.2/year to 1/year, p<0.001) 1
• Alternative: Low-dose NSAID with gastroprotection 1

If Chronic CPP Crystal Inflammatory Arthritis

Treatment hierarchy (strength of recommendation 79%): 1

1. First-line: Oral NSAID (with gastroprotection) and/or colchicine 0.5-1.0 mg daily 1
2. Second-line: Low-dose corticosteroids 1
3. Third-line: Methotrexate 5-10 mg/week (showed excellent response in refractory cases with mean improvement at 7.4 weeks) 1
4. Fourth-line: Hydroxychloroquine (NNT=2 for >30% reduction in joint swelling/tenderness) 1

If Concurrent Osteoarthritis with CPPD

Treat according to standard OA guidelines - the treatment objectives and options are identical to OA without CPPD 1. Caveat: Avoid intra-articular high molecular weight hyaluronan as it may trigger acute attacks 1.

Critical Pitfalls to Avoid

1. Don't treat asymptomatic calcifications - this leads to unnecessary medication exposure without benefit 1

2. Avoid high-dose colchicine regimens (1 mg loading then 0.5 mg q2h) - 100% incidence of severe side effects 1

3. Exercise extreme caution with NSAIDs in elderly patients - high risk of GI bleeding, cardiovascular events, and renal impairment in this population who often have comorbidities 1

4. Never use intravenous colchicine - high risk of serious toxicity and fatality 1

5. Don't assume physical therapy is contraindicated - while the question states it "cannot be treated with physical therapy," this likely refers to the calcifications themselves. For concurrent OA with CPPD, non-pharmacological modalities including appropriate exercise and physical measures remain part of comprehensive OA management 1

Screening for Underlying Causes

Always evaluate for associated metabolic conditions (strength of recommendation 89%): 1

• Hyperparathyroidism
• Hemochromatosis
• Hypomagnesemia

Treating these underlying conditions is essential when detected 1.

Evidence Quality Note

The treatment recommendations are primarily based on EULAR 2011 guidelines [1-1, which represent the highest quality systematic evidence available. Most recommendations extrapolate from gout treatment data due to limited CPPD-specific RCTs. The strongest evidence exists for intra-articular glucocorticoids for acute attacks and colchicine for prophylaxis 1.